PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 41872521

A genome-wide investigation of depression among individuals with and without irritability.

Julien St-Pierre·Jacky Jang·Corina Nagy·Laura Fiori·Gustavo Turecki·Josée Dupuis·Sahir Rai Bhatnagar·Massimiliano Orri
View original source ↗Export metadata ↓

Abstract

Individuals presenting with both depression and irritability may constitute a different group of individuals with respect to those presenting without irritability, but their biological differences remain unknown. We aimed to identify genetic variants associated with depression among individuals with and without irritability, highlight biological pathways, and test for genetic associations with other traits. We conducted a genome-wide association study (GWAS) using data from the UK Biobank (N&#x2009;=&#x2009;487,409). We identified a group of individuals presenting with depression and reporting never having experienced irritability (depression without irritability, n&#x2009;=&#x2009;35,857, 11.8%), and another with depression and reporting having experienced irritability (depression with irritability, n&#x2009;=&#x2009;23,613, 8.1%) and compared them to controls with no depression or irritability (n&#x2009;=&#x2009;268,012). The GWAS of depression without irritability identified 2 SNPs which reached genome-wide significance (P&#x2009;<&#x2009;5&#xd7;10-8; rs72795440 and rs1233494). The GWAS of depression with irritability (NGWAS&#x2009;=&#x2009;292,485) identified 3 SNPs reaching genome-wide significance (rs2815748, rs102275, and rs7227069). When comparing SNPs between depression phenotypes, 15 SNPs had significantly different effect sizes. Patterns of genetic correlation with 44 complex traits were overall similar between the 2 depression phenotypes, with the highest genetic overlap observed with anxiety for depression without irritability (rg&#x2009;=&#x2009;.77) and neuroticism for depression with irritability (rg&#x2009;=&#x2009;.76). This study shed light into common and distinct biological factors characterizing depression among individuals with and without irritability and contribute to better understanding the genetic architecture of depression to potentially inform treatment and personalized medicine.

Explore related subjects

HumansGenome-Wide Association StudyPolymorphism, Single NucleotideIrritable MoodFemaleGenetic Predisposition to DiseaseDepressionMaleMiddle AgedUnited KingdomAgedUK BiobankDepressive DisorderGenotypePhenotypeJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Julien St-Pierre, Jacky Jang, Corina Nagy, Laura Fiori, Gustavo Turecki, Jos&#xe9;e Dupuis, Sahir Rai Bhatnagar, Massimiliano Orri. 2026-03-24. A genome-wide investigation of depression among individuals with and without irritability.. https://doi.org/10.1038/s41380-026-03548-w

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗